Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Net Income towards Common Stockholders for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 8.66% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $7.0 billion (up 6.93% YoY), and the FY2025 full-year result was $6.8 billion, up 6.72% from the prior year.
• Net Income towards Common Stockholders climbed to $1.8 billion in Q2 2026 per TMO's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $2.2 billion in Q2 2022 and bottomed at $1.3 billion in Q2 2023.
• Historically, Net Income towards Common Stockholders has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2023.
• The widest YoY moves for Net Income towards Common Stockholders: up 14.72% in 2023, down 41.81% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $1.6 billion in 2022, then rose by 3.43% to $1.6 billion in 2023, then grew by 12.27% to $1.8 billion in 2024, then climbed by 9.29% to $2.0 billion in 2025, then retreated by 12.15% to $1.8 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $1.8 billion, $1.7 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.